© copyright 2000
United Nations Development
Programme (UNDP)
& Tomorrow's Advice s.a.r.l.

The views expressed in
this report not necessarily reflect those of the United Nations Development
Programme (UNDP) or the Ministry of Economy & Trade
Search    
TABLE OF CONTENTS

1. INTRODUCTION

Objectives
Beneficiaries
Implementation Strategy
Data Processing and Analyses
Expected Results of the Project
Meetings and Requested Data
Additional Sources
Main Limitations


2. STAKEHOLDERS OF THE LEBANESE PHARMACEUTICAL SECTOR

Public Sector
Private Sector
Other Important Players


3. INSTITUTIONAL FRAMEWORK OF THE LEBANESE PHARMACEUTICAL SECTOR

Establishment, Production, & Quality Control
Registration and Pricing
Bilateral Trade Agreements


4. STATUS OF THE PHARMACEUTICAL INDUSTRY IN LEBANON

Patented and Brand-Name Medicaments
Generic Medicaments
Product Classes
Market Size
Production Capacities
Market Segmentation
Quality Control
Raw Material
Local Demand
Marketing Efforts and Consumer Confidence
Packaging and Transportation of Pharmaceutical Products
Demand Outlook
Parallel Imports


5. PHARMACEUTICAL INDUSTRIES IN THE NEIGHBORING COUNTRIES

Jordan
Syria


6. MAIN ISSUES AND RECOMMENDATIONS


Appendix A
Stakeholders' main duties and obligations

Appendix B
Classification of the pharmaceutical products

Appendix C
Original Drug Patent Rights Duration

Appendix D
Lebanese Pharmaceutical Therapeutic Categories and Sub-Categories

Appendix E
Status of the Lebanese Pharmaceutical Manufacturers

Appendix F
Suggested Action Plan


Copyright 2002 drugavoid.com. All Rights Reserved. Legal Terms & Conditions. Designed & Developed by